Colorectal Tumor Cells

Colorectal tumors, primarily arising from the epithelial lining of the colon and rectum, are among the most prevalent malignancies worldwide. These cancers develop through a well-characterized multistep process involving the accumulation of genetic alterations, leading to the transition from normal mucosa to adenoma and ultimately carcinoma.

Our colorectal tumor cell line collection provides biologically relevant in vitro models for studying tumor initiation, progression, and metastasis, as well as for evaluating therapeutic strategies and investigating mechanisms of drug resistance in colorectal cancer.

Reliable Authentic Diverse Supported

Product List

Key Features & Expertise

Our colorectal tumor cell lines support a wide range of translational and mechanistic studies

Models Covering Tumor Progression Spectrum

Includes cell lines derived from primary tumors and metastatic lesions
Represents different stages of colorectal cancer development
Suitable for studies on tumor progression, invasion, and metastasis

Well-Defined Genetic and Molecular Background

Frequent mutations in key genes such as APC, KRAS, and TP53
Representation of major signaling pathways including Wnt/β-catenin and MAPK
Applicable to studies of tumorigenesis and targeted therapy response

Reliable Models for Drug Discovery

Widely used models such as HCT116, HT-29, and SW480
Suitable for high-throughput screening and pharmacological studies
Enable investigation of chemotherapy response and resistance mechanisms

FAQ

What types of colorectal tumor cell lines are included?

The collection includes a variety of colorectal cancer cell lines derived from both primary tumors and metastatic sites, covering different stages and biological characteristics of the disease.

What are the key genetic features of colorectal cancer models?

Colorectal cancer commonly involves mutations in genes such as APC, KRAS, and TP53, which drive tumor initiation and progression through pathways like Wnt/β-catenin and MAPK signaling.

How do I choose the right colorectal cancer cell line?

Selection depends on your research focus. Key considerations include:

Mutation profile ( e.g. , KRAS, BRAF, or TP53 status)
Origin (primary vs. metastatic tumor)
Drug sensitivity and resistance characteristics
Suitability for 2D, 3D, or organoid-based systems

Can these models be used to study tumor progression?

Yes, colorectal cancer follows a well-defined progression model involving sequential genetic alterations, making these cell lines particularly useful for studying tumor development and evolution.

Are colorectal tumor cell lines suitable for drug screening?

Yes, these models are widely used in drug discovery and screening, enabling evaluation of chemotherapeutics, targeted therapies, and combination treatment strategies in colorectal cancer.

Do these models reflect molecular heterogeneity?

While individual cell lines represent specific genetic backgrounds, using a panel of colorectal cancer models allows researchers to capture the molecular diversity of the disease, including variations in key oncogenic pathways.

How should colorectal tumor cell lines be stored and handled?

Cell lines are typically supplied as cryopreserved vials or shipped on dry ice. Upon receipt, they should be stored in liquid nitrogen and maintained using standard cell culture practices to ensure optimal performance.

Filters Clear all filters